UNC Health Care

Category: Hepatitis C

Stanley M. Lemon

July 28, 2014

UNC researchers discover how Hepatitis C virus persists for years

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.

Hepatitis C, Research

Read Article
Dr. Michael W. Fried of UNC is co-principal investigator of HCV-TARGET.

August 29, 2013

FDA, academia and industry team up to end hepatitis C

The Hepatitis C Therapeutic Registry and Research Network, or HCV-TARGET, is led jointly by investigators at the University of North Carolina School of Medicine and University of Florida and is sponsored in part by multiple pharmaceutical companies.

Chronic Illness, Hepatitis C, Research

Read Article
A cultured liver cancer cell infected with Hepatitis C. The virus

December 18, 2012

UNC researchers discover how hepatitis C virus reprograms human liv...

Researchers in the laboratory of Stanley M. Lemon, MD, outline the critical role the microRNA known as miR-122 plays in the life cycle of the hepatitis C virus.

Hepatitis C, Hepatology, Innovation, Research

Read Article
Michael W. Fried

September 14, 2011

24-week hepatitis C treatment as effective as 48-week treatment

A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.

Chronic Illness, Hepatitis C, Treatment

Read Article